Griponal

Griponal is a well-established pharmaceutical product primarily recognized in the Mediterranean and European markets as an effective treatment for the symptoms of the common cold and influenza. The medication typically combines paracetamol with an antihistamine, such as chlorphenamine, to address fever, pain, and respiratory congestion simultaneously.

The brand has its origins in Portugal, where it was developed by the Laboratórios Vitória team. Over the decades, it has become a household name within its domestic market for over-the-counter flu relief. The production remains centered in specialized pharmaceutical facilities in Portugal, adhering to European medical standards.

Today, the brand is owned by the Menarini Group, an Italian pharmaceutical giant that acquired Laboratórios Vitória. The Menarini Group is one of the world's leading private pharmaceutical companies, ensuring that Griponal benefits from an international distribution network while maintaining its traditional identity as a Portuguese health care staple.